Request for Notification From Industry Organizations Interested in Participating in the Selection Process for a Nonvoting Industry Representative on the Tobacco Products Scientific Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Tobacco Products Scientific Advisory Committee, 43140-43141 [E9-20483]
Download as PDF
<![CDATA[
43140
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices
Estimated Total Annual Burden
Hours: 250
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Fax: 202–395–7245,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: August 21, 2009.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. E9–20547 Filed 8–25–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Summary Data Component,
National Child Abuse and Neglect Data
System (NCANDS).
OMB No.: 0980–0229.
Description: The Child Abuse and
Neglect Treatment Act (42 U.S.C. 5101
et seq.) as amended requires States to
annually work with the Secretary to
provide to the maximum extent
practical, a report that includes 12 data
items listed in the statute. The National
Child Abuse and Neglect Data System
(NCANDS), administered by the
Children’s Bureau, meets this reporting
requirement. In addition, the
amendments of 1988 require that the
data system shall be universal and case
specific and integrated with other casebased foster care and adoption data
collected by the Secretary. There are
two data components, the Detailed Case
Data Component (DCDC), which
includes the case-level data submitted
through the Child File and some
aggregated data submitted through the
Agency File, and the Summary Data
component (SC), which is used by
States that cannot submit case-level
data. No changes are being requested.
The Summary Data Component will be
phased out over the next few years as
the number of States that can complete
the Child File increases.
Respondents: State Child Welfare
Agencies.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Child File ..........................................................................................................
Agency File ......................................................................................................
Summary Data Component (SDC) ..................................................................
Additional Information
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
jlentini on DSKJ8SOYB1PROD with NOTICES
OMB Comment
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following:
Office of Management and Budget,
Paperwork Reduction Project. Fax: 202–
VerDate Nov<24>2008
17:05 Aug 25, 2009
Jkt 217001
Dated: August 21, 2009.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. E9–20546 Filed 8–25–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0383]
Request for Notification From Industry
Organizations Interested in
Participating in the Selection Process
for a Nonvoting Industry
Representative on the Tobacco
Products Scientific Advisory
Committee and Request for
Nominations for a Nonvoting Industry
Representative on the Tobacco
Products Scientific Advisory
Committee
AGENCY:
Food and Drug Administration,
HHS.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Average burden hours per
response
1
1
1
80
24
32
50
50
2
395–7245. Attn: Desk Officer for the
Administration for Children and
Families.
Estimated Total Annual Burden
Hours: 5,264.
Number of responses per
respondent
ACTION:
Total burden
hours
4,000
1,200
64
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting that
any industry organizations interested in
participating in the selection of a
nonvoting industry representative to
serve on its Tobacco Products Scientific
Advisory Committee notify FDA in
writing. A nominee may either be selfnominated or nominated by an
organization to serve as a nonvoting
industry representative. Nominations
will be accepted for current vacancies
effective with this notice. Elsewhere in
this issue of the Federal Register, FDA
is publishing two separate documents
announcing the establishment of the
committee and the request for
nomination of the Tobacco Products
Scientific Advisory Committee.
DATES: Any industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent industry interests
must send a letter stating the interest to
FDA by September 25, 2009, for
vacancies listed in the notice.
Concurrently, nomination material for
E:\FR\FM\26AUN1.SGM
26AUN1
43141
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices
prospective candidates should be sent to
FDA by September 25, 2009.
ADDRESSES: All nominations for
membership should be sent
electronically to cv@oc.fda.gov, or by
mail to Advisory Committee Oversight &
Management Staff, 5600 Fishers Lane
(HF–4), rm. 14C03, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT: Erik
P. Mettler, Office of Policy, Office of the
Commissioner, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 1, rm. 4324, Silver Spring,
MD 20993, 301–796–4711, FAX: 301–
847–3541, e-mail:
erik.mettler@fda.hhs.gov.
The
agency requests nominations for
nonvoting industry representatives on
the Tobacco Products Scientific
Advisory Committee. Elsewhere in this
issue of the Federal Register, FDA is
publishing two separate documents
announcing the establishment of the
committee and the request for
nomination of the Tobacco Products
Scientific Advisory Committee.
SUPPLEMENTARY INFORMATION:
I. Center for Tobacco
Tobacco Products Scientific Advisory
Committee
jlentini on DSKJ8SOYB1PROD with NOTICES
The Tobacco Products Scientific
Advisory Committee advises the
Commissioner or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The Committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information, and
recommendations to the Commissioner
of Food and Drugs.
The Committee shall include three
nonvoting members who are identified
with industry interests. These members
shall include one representative of the
tobacco manufacturing industry, one
representative of the interests of tobacco
growers, and one representative of the
interests of the small business tobacco
manufacturing industry. This final
position can be filled on a rotating,
sequential basis by representatives of
different small business tobacco
manufacturers based on areas of
expertise relevant to the topics being
considered by the Committee.
CONTACT)
within 30 days of publication
of this document. Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest, attaching a
complete list of all such organizations;
and a list of all nominees along with
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for the Tobacco Products
Scientific Advisory Committee. The
interested organizations are not bound
by the list of nominees in selecting a
candidate. However, if no individual is
selected within 60 days, the
Commissioner of Food and Drugs will
select the nonvoting member to
represent industry interests.
III. Application Procedure
Individuals may self nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. A current
curriculum vitae and the name of the
committee of interest should be sent to
the FDA contact person within the 30
days. FDA will forward all nominations
to the organizations expressing interest
in participating in the selection process
for the committee. (Persons who
nominate themselves as nonvoting
industry representatives will not
participate in the selection process).
FDA has a special interest in ensuring
that women, minority groups,
individuals with physical disabilities,
and small businesses are adequately
represented on its advisory committees,
and therefore, encourages, nominations
for appropriately qualified candidates
from these groups.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: August 19, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–20483 Filed 8–25–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Industry Exchange Workshop on Food
and Drug Administration Drug and
Device Requirements; Public
Workshop
AGENCY:
ACTION:
COST OF REGISTRATION
Any industry organization interested
in participating in the selection of an
appropriate nonvoting member to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
17:05 Aug 25, 2009
Notice of public workshop.
SUMMARY: The Food and Drug
Administration (FDA) Philadelphia
District, in cosponsorship with the
Society of Clinical Research Associates
(SoCRA) is announcing a public
workshop entitled: ‘‘FDA Clinical Trial
Requirements, Regulations, Compliance
and GCP.’’ This 2-day public workshop
is intended to provide information
about FDA clinical trial requirements to
the regulated industry.
Date and Time: The public workshop
will be held on October 21, 2009, from
8:30 a.m. to 5 p.m. and October 22,
2009, from 8:30 a.m. to 5 p.m.
Location: The public workshop will
be held at the Hyatt Regency Pittsburgh
International Airport, 1111 Airport
Blvd., Pittsburgh, PA 15231, 724–899–
1234 or 1–800–233–1234.
Attendees are responsible for their
own accommodations. To make
reservations at the Hyatt Regency Hotel,
contact the Hyatt Regency Hotel.
Contact: Marie Falcone, Food and
Drug Administration, U.S.
Customhouse, 200 Chestnut St., rm. 900,
Philadelphia, PA 19106, 215–717–3703,
FAX: 215–597–4660, e-mail:
marie.falcone@fda.hhs.gov.
Registration: You are encouraged to
register by October 19, 2009. The
SoCRA registration fees cover the cost of
facilities, materials, and breaks. Seats
are limited; please submit your
registration as soon as possible. Course
space will be filled in order of receipt
of registration. Those accepted in to the
course will receive confirmation.
Registration will close after the course is
filled. Registration at the site is not
guaranteed but may be possible on a
space available basis on the day of the
public workshop beginning at 8 a.m.
The cost of registration is as follows:
II. Selection Procedure
VerDate Nov<24>2008
Food and Drug Administration,
HHS.
Jkt 217001
PO 00000
Affiliation
Fee
FDA Employee
Government (Non-Member)
Frm 00048
Fmt 4703
Sfmt 4703
Fee Waived
$525.00
E:\FR\FM\26AUN1.SGM
26AUN1
]]>Agencies
[Federal Register Volume 74, Number 164 (Wednesday, August 26, 2009)]
[Notices]
[Pages 43140-43141]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20483]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0383]
Request for Notification From Industry Organizations Interested
in Participating in the Selection Process for a Nonvoting Industry
Representative on the Tobacco Products Scientific Advisory Committee
and Request for Nominations for a Nonvoting Industry Representative on
the Tobacco Products Scientific Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that any
industry organizations interested in participating in the selection of
a nonvoting industry representative to serve on its Tobacco Products
Scientific Advisory Committee notify FDA in writing. A nominee may
either be self-nominated or nominated by an organization to serve as a
nonvoting industry representative. Nominations will be accepted for
current vacancies effective with this notice. Elsewhere in this issue
of the Federal Register, FDA is publishing two separate documents
announcing the establishment of the committee and the request for
nomination of the Tobacco Products Scientific Advisory Committee.
DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests must send a letter stating the interest to FDA by September
25, 2009, for vacancies listed in the notice. Concurrently, nomination
material for
[[Page 43141]]
prospective candidates should be sent to FDA by September 25, 2009.
ADDRESSES: All nominations for membership should be sent electronically
to cv@oc.fda.gov, or by mail to Advisory Committee Oversight &
Management Staff, 5600 Fishers Lane (HF-4), rm. 14C03, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT: Erik P. Mettler, Office of Policy,
Office of the Commissioner, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 1, rm. 4324, Silver Spring, MD 20993, 301-796-
4711, FAX: 301-847-3541, e-mail: erik.mettler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The agency requests nominations for
nonvoting industry representatives on the Tobacco Products Scientific
Advisory Committee. Elsewhere in this issue of the Federal Register,
FDA is publishing two separate documents announcing the establishment
of the committee and the request for nomination of the Tobacco Products
Scientific Advisory Committee.
I. Center for Tobacco
Tobacco Products Scientific Advisory Committee
The Tobacco Products Scientific Advisory Committee advises the
Commissioner or designee in discharging responsibilities as they relate
to the regulation of tobacco products. The Committee reviews and
evaluates safety, dependence, and health issues relating to tobacco
products and provides appropriate advice, information, and
recommendations to the Commissioner of Food and Drugs.
The Committee shall include three nonvoting members who are
identified with industry interests. These members shall include one
representative of the tobacco manufacturing industry, one
representative of the interests of tobacco growers, and one
representative of the interests of the small business tobacco
manufacturing industry. This final position can be filled on a
rotating, sequential basis by representatives of different small
business tobacco manufacturers based on areas of expertise relevant to
the topics being considered by the Committee.
II. Selection Procedure
Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of
this document. Within the subsequent 30 days, FDA will send a letter to
each organization that has expressed an interest, attaching a complete
list of all such organizations; and a list of all nominees along with
their current resumes. The letter will also state that it is the
responsibility of the interested organizations to confer with one
another and to select a candidate, within 60 days after the receipt of
the FDA letter, to serve as the nonvoting member to represent industry
interests for the Tobacco Products Scientific Advisory Committee. The
interested organizations are not bound by the list of nominees in
selecting a candidate. However, if no individual is selected within 60
days, the Commissioner of Food and Drugs will select the nonvoting
member to represent industry interests.
III. Application Procedure
Individuals may self nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting industry
representative. A current curriculum vitae and the name of the
committee of interest should be sent to the FDA contact person within
the 30 days. FDA will forward all nominations to the organizations
expressing interest in participating in the selection process for the
committee. (Persons who nominate themselves as nonvoting industry
representatives will not participate in the selection process).
FDA has a special interest in ensuring that women, minority groups,
individuals with physical disabilities, and small businesses are
adequately represented on its advisory committees, and therefore,
encourages, nominations for appropriately qualified candidates from
these groups.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: August 19, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-20483 Filed 8-25-09; 8:45 am]
BILLING CODE 4160-01-S
